Portfolio (Quarterly)
Guide ↗
SUPERSTRING CAPITAL MANAGEMENT LP
· CIK 0001931118| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | QUINCE THERAPEUTICS INC | — | 858,711.0 | $2.9M | 1.54% | NEW | — | $3.35 | — |
| 22 | — | AVALO THERAPEUTICS INC | — | 153,313.0 | $2.8M | 1.49% | NEW | — | $18.16 | — |
| 23 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 96,334.0 | $2.8M | 1.49% | NEW | — | $28.86 | -33.8% |
| 24 | PVLA | PALVELLA THERAPEUTICS INC NE | Healthcare | 25,469.0 | $2.7M | 1.43% | NEW | — | $104.67 | +38.8% |
| 25 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 88,308.0 | $2.4M | 1.28% | NEW | — | $27.16 | +28.8% |
| 26 | — | ASSEMBLY BIOSCIENCES INC | — | 65,273.0 | $2.2M | 1.19% | NEW | — | $34.01 | — |
| 27 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 255,370.0 | $2.1M | 1.12% | NEW | — | $8.18 | +28.7% |
| 28 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 360,000.0 | $1.9M | 1.03% | NEW | — | $5.33 | -23.9% |
| 29 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 148,292.0 | $1.9M | 0.99% | NEW | — | $12.52 | +36.0% |
| 30 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 58,677.0 | $1.5M | 0.83% | NEW | — | $26.29 | +19.2% |
| 31 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 38,022.0 | $1.5M | 0.78% | NEW | — | $38.21 | +43.7% |
| 32 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 43,230.0 | $1.3M | 0.72% | NEW | — | $31.12 | -42.7% |
| 33 | RZLT | REZOLUTE INC | Healthcare | 513,765.0 | $1.2M | 0.65% | NEW | — | $2.36 | +84.1% |
| 34 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 26,249.0 | $1.1M | 0.58% | NEW | — | $41.21 | +128.3% |
| 35 | SPRB | SPRUCE BIOSCIENCES INC | Healthcare | 12,137.0 | $1.1M | 0.57% | NEW | — | $87.11 | -50.1% |
| 36 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 69,496.0 | $912K | 0.49% | NEW | — | $13.12 | -53.4% |
| 37 | GMAB | GENMAB A/S | Healthcare | 29,162.0 | $898K | 0.48% | NEW | — | $30.80 | -6.1% |
| 38 | — | PALISADE BIO INC | — | 367,103.0 | $863K | 0.46% | NEW | — | $2.35 | — |
| 39 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 72,060.0 | $815K | 0.44% | NEW | — | $11.31 | -69.1% |
| 40 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 31,738.0 | $730K | 0.39% | NEW | — | $23.00 | +29.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%